Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin-Reference-Cited by-同舟云学术

Clinical effects of early angiotensin-converting enzyme inhibitor treatment for acute myocardial infarction are similar in the presence and absence of aspirin

Published:2000-06 Issue:7 Volume:35 Page:1801-1807
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Latini Roberto,Tognoni Gianni,Maggioni Aldo P.,Franzosi MariaGrazia,Santoro Eugenio,Baigent Colin,Chen Zheng-Ming,Collins Rory,Peto Richard,Sleight Peter,Braunwald Eugene,Pfeffer Marc,Flather Marcus,Kjekshus John,Køber Lars,Liu Li-Sheng,Wang Wen,Pizzetti Fabrizio,Swedberg Karl,Tavazzi Luigi,Yusuf Salim

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction;Pfeffer;N Engl J Med,1992

2. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure;Lancet,1993

3. A clinical trial of the angiotensin-converting enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction;Kober;N Engl J Med,1995

4. Oral captopril versus placebo among 13,634 patients with suspected acute myocardial infarction;Lancet,1995

5. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction;Swedberg;N Engl J Med,1992

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigating the predictive value of microRNA21 as a biomarker in induced myocardial infarction animal model;Gene Reports;2022-06

2. ACE Inhibition Modulates Myeloid Hematopoiesis after Acute Myocardial Infarction and Reduces Cardiac and Vascular Inflammation in Ischemic Heart Failure;Antioxidants;2021-03-05

3. Estudio farmacodinámico del policomprimido cardiovascular: ¿existe algún tipo de interacción entre los monocomponentes?;Revista Española de Cardiología;2021-01

4. Pharmacodynamic study of the cardiovascular polypill. Is there any interaction among the monocomponents?;Revista Española de Cardiología (English Edition);2021-01

5. Letter to the editor: The role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in developing a COVID-19 comorbidity-based host risk score;Critical Care;2020-05-19